DibonaG.F.: Renal neural activity in hepatorenal syndrome.Kidney International1984; 25: 841–853.
2.
CoratelliP., PassavantiG., MunnoI.: New trends in hepatorenal syndrome.Kidney International1985; 28: S143–147.
3.
PapperS.: The hepatorenal syndrome.Clinical Nephrology1975; 4: 41–44.
4.
ZipserRD., RadvanGH., KronborgI.J.: Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evidence for increased vasoconstrictor and decreased vasodilator factors.Gastroenterology1983; 84: 697–703.
5.
LevyM., and WexlerM.J.: Salt and water balance in liver disease.Hospital Practice1984; 19: 57–71.
6.
LevyM.: Sodium retention and ascites formation in dogs with experimental portal cirrhosis.American Journal of Physiology1977; 233: F572–F585.
7.
EpsteinM.: Renal complications of liver disease.Clinical Symposia1985; 37: 3–32.
8.
ZipserRD., KronborgI., RectorW.: Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.Gastroenterology1984; 87: 1228–1232.
9.
IwatsukiS., PopovitzerMM., CormanJ.L.: Recovery from “hepatorenal syndrome” after orthotopic liver transplantation.New England Journal of Medicine1973; 289: 1155–1160.
10.
WongP.Y., McCoyG.C., SpielbergA.: The hepatorenal syndrome.Gastroenterology1979; 77: 1326–1334.
